Ann: Appendix 4C, page-11

Missed the CON call, unfortunately. Did he mention why they have sold on average only 3 sales per clinical site (of which there are 12), over the last 3 months since FDA approval? That's one 1 unit per month from these trained up sites who are familiar with the procedures given they were involved in trials.

They haven't hit anywhere near manufacturing limits, so I hope they're not using the production commissioning as an excuse.

I have also become a little wary of the management communication. I'm not sure what low ball sales expectations they had such that they are exceeding these expectations at only 1 sale per site per month.

With 17 trained sales guys on board now, they should each be hitting 10's of units per week from here onward, I would have thought.